Chinapeptides: Net profit loss of 597 million yuan in the first half of 2025.

Announcement from Sinopharm: In the first half of 2025, the company's operating income was 4.919 billion yuan, a year-on-year decrease of 73.06%. The net profit was a loss of 597 million yuan, compared to a net profit of 2.234 billion yuan in the same period last year. During the reporting period, influenced by multiple factors such as a decrease in people's willingness to be vaccinated and changes in market demand, the company reached a consensus with MSD to adjust the procurement and supply rhythm of HPV vaccines for the current year, and continue to conduct demand assessments to jointly respond to market changes.